Skip to content Skip to footer
Subscribe Now
Thoughtspot_Saurabh Chaubey
THOUGHTSPOT

Reinventing Marketing Strategies for Biopharma Companies

Shots: Conventional marketing strategies face challenges due to a lack of next-generation tools integrated into existing models. Explore the nuances of biopharma marketing, highlighting its key elements and the advantages it offers. Discover PharmaShots’ 4D model, which has been instrumental in shaping the biopharma marketing landscape. Strategically crafted marketing plans are essential for long-term sustainability,…
January 22, 2025

Read more

ThoughtSpot_Saurabh Chaubey2
THOUGHTSPOT

Bridging the Biopharma Gap with Consulting Firms

Shots: In the extremely competitive biopharma industry, it’s never too soon to learn about the players who help biopharma companies understand the evolving landscape of the biopharma industry Consulting firms are instrumental in guiding biopharma companies in decision-making, understanding the regulatory challenges, and market dynamics This article from PharmaShots unfolds the benefits of onboarding a…
November 13, 2024

Read more

ThoughtSpot_Saurabh Chaubey5
THOUGHTSPOT

How Innovative Public Relation Solutions Shape the Biopharma Industry?

Shots:  In the internet-driven world where social media shape opinions and perspectives, it is imperative for companies in the biopharma industry to leverage innovative PR solutions PR solutions offer significant advantages for biopharma companies that help build their brand values, increase credibility amongst consumers and stakeholders, and much more With hand-curated offerings designed especially for…
August 6, 2024

Read more

Viewpoints_Jesse Mendelsohn
VIEWPOINTS

Drug Pricing & Rebate Management: Jesse Mendelsohn from Model N in Dialogue Exchange with PharmaShots

Shots: Drug pricing reforms from the IRA continue to impact pharmaceutical companies. The rebates ensued from the IRA guidelines are heavily affecting the revenues of biopharma companies Today, at PharmaShots we have Jesse Mendelsohn, Sr. Vice President at Model N shedding light on the company’s recently launched solution called Medicare Part D inflation rebate-per-unit With…
July 1, 2024

Read more

RNAi Therapeutic Top 20 2024
TOP 20

Top 20 RNAi Therapeutic Companies of 2024

Shots: RNAi therapeutics are innovative medications that enable rapid identification of specific inhibitors of disease targets across a wide range of molecule classes. Several biopharma companies are investing in RNAi therapeutics extravagantly to maintain a healthy foothold in innovative medicines In 2023, the global RNAi drug delivery market size was valued at $84.1B and is…
April 25, 2024

Read more

e-Brain OncoVision Connecting the Dots in Cancer Care
EVENTS

e-Brain OncoVision: Connecting the Dots in Cancer Care

Gear up for the most awaited metaverse-based global event! Don’t miss out on this enlightening conference focussed on Oncology domains by Ingenious E-Brain. The virtual event “e-Brain OncoVision: Connecting the Dots in Cancer Care” is scheduled for February 15th (9:00AM EST) to February 16th, 2024 (5:30PM EST) Featuring renowned speakers from leading biopharma companies & organizations, the…
January 18, 2024

Read more

Know Your Investor: Google Ventures
INSIGHTS+

Know Your Investor: Google Ventures

Shots: An investment arm of Alphabet Inc., Google Ventures Management Company colossally in seed stage companies, in diverse fields ranging from software and internet to healthcare, life sciences, and artificial intelligence among others Since 2016, GV has shifted its focus from seed-stage companies to evolved companies. With over $8B worth of assets under the management…
December 27, 2023

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]